Data / Form D filings / Andira Medicine Inc.
Andira Medicine Inc.: Form D filing
Andira Medicine Inc., a company in North Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2026. The latest, on October 9, 2026, reports $120,000 sold of a $120,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 507-725 Marine Drive, North Vancouver, British Columbia, Canada, V7M 0
- Phone
- (604) 335-6348
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1916630
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 9 | New notice | $120,000 | $120,000 | 1 | Sep 24 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dana Lambert | Director, Executive Officer | |
| Ethan Russo | Director, Executive Officer | |
| Michael Stuart Wall | Director, Executive Officer | |
| Ammad Shorbaji | Executive Officer | |
| Janette Lyons | Executive Officer |
Every Form D from the week of Oct 5 · All recent Other filings
Read from SEC EDGAR. Amount sold is what Andira Medicine Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.